De definitieve gids voor genbewerking.
Menu
Home Leren Nieuws Vraag de Atlas
Verkennen Technologieën Ziekten Behandelingen Klinische onderzoeken Bedrijven Wetenschappers Genen Onderzoek Instellingen
Verder dan geneeskunde Landbouw Ethiek Investeren Wereldkaart
Leren & Tools Begin hier Woordenlijst A–Z Vergelijk technologieën Tijdlijn Lijsten & Rankings AI-agents ★ Opgeslagen API
Over Over ons Methodologie Databronnen Redactioneel beleid Contact Disclaimers

🧭 Begeleide weergave
Nieuw in de genetica? We leggen elk begrip uit terwijl je bladert, in gewone taal. Dezelfde pagina's, met de hulp ingebouwd.

⚡ Expertvisie
Je kent de biologie al. Alleen de inhoud — helder en compact, zonder extra uitleg. Dit is de standaardweergave.

Interfacetaal
Lichte modus

Technology · Large-cargo editing

Recombinases and integrases

Enzymes that cut and rejoin DNA at defined sites, able to insert whole genes rather than edit single letters.

Preclinical DNAlarge insertionsno double-strand break
Preclinical research Tested in cells and animals only. Most preclinical programmes never reach people, and animal results often do not carry over.

Eenvoudige uitleg

Every editor described so far changes small amounts of text. Recombinases move paragraphs. They are enzymes that recognise a specific short sequence and swap the DNA around it — so if you first mark a safe spot in the genome, a recombinase can drop an entire working gene into that spot in one go.

Dieper ingaan

Site-specific recombinases (Cre, Flp) and serine integrases (Bxb1, PhiC31) catalyse strand exchange between defined recognition sites, integrating, excising or inverting sequence without producing free double-strand breaks or depending on host repair pathways. Because natural recognition sites are rare in human genomes, therapeutic strategies pair a programmable editor that writes a landing site with an integrase that then inserts the cargo — the approach behind PASTE and related methods, which can integrate sequences of many kilobases.

Why large insertions matter

Some diseases cannot be treated by tweaking sequence because the gene is enormous or the mutations are scattered across it in hundreds of different places. Duchenne muscular dystrophy is the canonical example: the dystrophin gene is the largest in the human genome, and a per-mutation editing strategy would mean a different medicine for almost every family. Inserting one working copy at a defined location would be a single solution for everyone — which is why integrase approaches attract so much interest despite being preclinical.

Why large insertions matter
A recombinase exchanging a block of sequence between two DNA strands. Illustration generated for The CRISPR Atlas — a visual aid, not a photograph or a literal depiction of molecular structure.

Sources

Connected in the Atlas

Every entry on this site is linked to the others it relates to. These connections are part of the record, not a search result.

Alleen educatieve informatie Deze pagina is een naslagbron, geen medisch advies. Onderzoeks- en regelgevingsstatus veranderen; controleer de datum van de laatste update hierboven en verifieer belangrijke informatie bij de vermelde primaire bronnen.